AngioDynamics to Present at the UBS Global Healthcare Conference

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) announced that CEO Jim Clemmer and CFO Stephen Trowbridge will present at the UBS Global Healthcare Conference on May 23, 2022, at 4:15 p.m. ET. The presentation will focus on the company's innovations in medical technology aimed at restoring blood flow, enhancing cancer treatments, and improving patient quality of life. A live webcast will be available on the company’s website, with replay options following the event. AngioDynamics is recognized for addressing critical healthcare needs with its advanced technologies.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday, May 23, 2022.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220516005937/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

What event will AngioDynamics participate in on May 23, 2022?

AngioDynamics will present at the UBS Global Healthcare Conference on May 23, 2022.

What time is the AngioDynamics presentation at the UBS Global Healthcare Conference?

The presentation is scheduled for 4:15 p.m. ET.

Who are the presenters from AngioDynamics at the conference?

Jim Clemmer, President and CEO, and Stephen Trowbridge, Executive Vice President and CFO, will present.

Where can I watch the AngioDynamics conference presentation?

The presentation will be available via live webcast on AngioDynamics' website in the Investors section.

What is the focus of AngioDynamics' presentation?

The presentation will focus on the company's commitment to restoring blood flow, expanding cancer treatment options, and enhancing patient quality of life.